Abstract
Methods
For the purpose of the study, the articles related to the subject of interest were systematically searched in seven electronic databases. Special attention was given to the studies examining T. gondii seropositivity level in depressed patients and controls.
Results
The search process resulted in the identification of a total of 30 publications meeting the inclusion criteria and published up to April 2018 for the systematic review. Furthermore, 29 studies met the inclusion criteria to be entered into meta-analysis. Our meta-analysis involved the review of cross-sectional studies including 1657 depressed patients and 19565 individuals as controls and case-control studies entailing 1311 depressed cases and 6015 controls without depression. 1582 depressed people participated in cross-sectional studies whose results were reported as odds ratio (OR). In addition, the total number of participants was 15068 in this type of studies. Statistical analysis indicated that the pooled OR of the risk a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
Introduction

Methods
Design and protocol registration
The preferred reporting items for systematic reviews and meta-analysis (PRISMA) was used for performing this study (S1 Table) [16] . The study protocol (CRD42017069169) was registered on the site of the international prospective register of systematic reviews (PROSPERO) [17] .
Search strategy
For the purpose of the study, the original studies investigating the association between toxoplasmosis and depression and published up to April 2018 were systematically searched in several databases, including "PubMed", "Science Direct", "Scopus", "ProQuest", "EMBASE", "Web of Science", and "Google Scholar" with no language restriction. The search process was accomplished using the following keywords in combination or alone: "Toxoplasma gondii", "Toxoplasmosis", "Prevalence", "Seroprevalence", "Depression", "Depressed", "Depressive", "Psychic disorder", "Mental disorder", "Systematic review", and "Meta-analysis". In order to achieve additional eligible articles, the reference lists of the retrieved articles were checked. In addition, unpublished studies were not investigated in the review process.
Inclusion and exclusion criteria
We included articles based on the following criteria: 1) cross-sectional and case-control studies investigating the relationship between toxoplasmosis and MDD, 2) the studies performed only on humans, 3) original articles with available full texts in all languages, and 4) studies providing detailed information on the prevalence of toxoplasmosis using serology (i.e., IgG and/or IgM antibodies) and molecular tests in people with the diagnosis of depression according to the DSM-5 criteria [12] . On the other hand, the exclusion criteria entailed: 1) studies not representative for our target population, 2) studies performed on animal models; 3) low-quality data, 4) case reports or case series, and 5) studies with incomplete data.
Study selection and data extraction
All identified titles and abstracts were independently assessed for eligibility by two authors using a pilot form. Any disagreements in the selected studies were resolved by discussion, and the arbitration of the third author. The included papers were attentively studied, and the information about the study location, number and percentage of the positive and negative cases of toxoplasmosis in patients and controls, number and percentage of depressed patients and controls, age, gender, method of studies, all laboratory results, and Odds ratio (OR) were extracted using a data extraction form.
Quality assessment
Assessment of methodological quality was performed by two investigators using the Newcastle-Ottawa Scale [18] with separate criteria for case-control and cross-sectional studies to evaluate the selection, comparability, and outcome of the included studies. In the case-control studies, the scores of 7-9, 4-6, and � 3 were representative of high, moderate, and low quality, respectively. Furthermore, regarding the cross-sectional studies, the scores of 6-7, 3-5, and 1-2 indicated high, moderate, and low quality, respectively. In this regard, the higher scores were awarded to the studies of higher quality. The quality of the included studies is reported in S2 Table.
Statistical analysis
The meta-analysis was performed to evaluate the potential for the association between T. gondii infection and MDD using Stata software, version 14 (StataCorp, College Station, TX, USA) [19] . The heterogeneity index among different studies was determined using Cochran's Q test [19] . The ORs of the risk of anti-T. gondii IgG and IgM antibodies in depressed patients were estimated using a random effects model. The relationship between toxoplasmosis and MDD was expressed as OR for seven cross-sectional studies. For the other five cross-sectional studies presenting results as number and percentage, the OR was calculated. In addition, for the 17 case-control studies not reporting the association between toxoplasmosis and depression as OR, we calculated OR and 95% confidence interval (CI) using the raw number of individuals in case and control groups. Finally, 29 articles were analyzed. An OR > 1 indicates the positive effect of Toxoplasma on MDD, and an OR < 1 shows that toxoplasmosis has a protective effect against MDD.
A funnel plot and Egger's regression test were used to check for the presence of publication bias, and the significance level was less than 0.1 [20] . Furthermore, a sensitivity analysis was performed to identify the effect of each study on the overall results through removing each study. The subgroup analysis was conducted according to the type of the study. Also, analysis of the effect of study quality on the overall effect was performed.
Results
As shown in Fig 1, the literature search resulted in the identification of 13,606 related articles. After eliminating the duplicate publications, a total of 12,587 articles remained. Following a thorough examination of the titles and abstracts of the papers, a total of 45 studies were extracted. Finally, out of 45 unique records, 30 articles were eligible to be included in this systematic review, 29 cases of which met our inclusion criteria for meta-analysis. A study conducted by Groër was not analyzed due to the lack of a control group [21] .
According to the results of the meta-analysis, the pooled OR of the risk of anti-T. gondii IgG antibody in the depressed subjects investigated in the included studies was 1.15 (95% CI: 0.95-1.39) (Fig 2) . The test of heterogeneity revealed a significant heterogeneity among the studies (Q = 80.58%, p = 0.000). Publication bias was evaluated using the Egger's test (p = 0.148). On the other hands, as funnel plot shows the graph is symmetric and there is no publication bias (Fig 3) . Furthermore, the OR of the risk of anti-T. gondii IgM antibody in depressed individuals was estimated at 1.69 (95% CI: 0.72-3.96).
The results of the sensitivity analysis demonstrated that the impact of each study on overall estimates was not significant (Fig 4) . According to the random effects model, the combined ORs of the risk of anti-T. gondii IgG antibody in depressed subjects based on the type of research in cross-sectional and case-control studies were 0.88 (95% CI: 0.75-1.03) and 1.67 (95% CI: 1.29-2.16), respectively (Figs 5 and 6). The quality assessment scores were evaluated as effective factors in overall estimation using meta regression; it has been shown that the impact of quality of each study on the overall estimates was not statistically significant (p = 0.275).
A total of 1657 patients with MDD and 19565 controls in cross-sectional studies and 1311 depressed cases and 6015 controls in case-control studies were included in the meta-analysis. Furthermore, 1582 depressed people participated in cross-sectional studies and their results were reported as OR. The total number of participants in this type of study was 15068.
Information and characteristics of the included publications are shown in Tables 1 and 2 . The studies reviewed in this research were from 13 countries. Most of the studies were conducted in the USA (n = 7), followed by Mexico (n = 5), Iran (n = 3), Germany, Egypt, Saudi Arabia, Czech Republic, China (n = 2), United Kingdom, Turkey, Austria, New Zealand, and Finland (n = 1). Furthermore, the most widely used diagnostic test to evaluate Toxoplasma antibodies was the enzyme-linked immunosorbent assay (ELISA) method.
Discussion
This systematic review and meta-analysis aimed to quantify the pooled ORs of anti-T. gondii IgG and IgM antibodies in depressed patients and compare them with those of control groups. The results obtained from the current study showed that the overall ORs of anti-T. gondii IgG and IgM antibodies in patients with MDD were 1.15 (95% CI: 0.95-1.39) and 1.69 (95% CI: 0.72-3.96), respectively. Based on these results, toxoplasmosis is not considered a risk factor for depressed patients. There are several reasons accounting for these negative findings: 1) infectious agent does not play an etiologic role in major depression, 2) the infectious agent has attended earlier in individuals' life but are no longer detectable [22] .
Based on the results of the meta-analysis, the depressed patients had a lower seroprevalence of T. gondii as compared to the controls. Major depression showed no association with antiToxoplasma IgG and anti-Toxoplasma IgM. Our results are inconsistent with those of the systematic reviews evaluating the association between toxoplasmosis and psychiatric disorders, including epilepsy (OR = 2.25) [11] , bipolar disorder (OR = 1.26) [8] , obsessive-compulsive disorder (OR = 1.96) [51] , schizophrenia (OR = 1.81) [9] , and addiction (OR = 1.91) [9] .
On the other hand, our results are in line with those of a couple of previous meta-analyses that showed no association between T. gondii infection and depression [9, 15] . Wang et al. in 2014 [15] evaluated the relationship between different infectious agents and depression. In this meta-analysis, only three studies had addressed the relationship between T. gondii infection and depression. After analyzing various studies, no significant association was found, and the OR was calculated as 1.36. All three studies were included in the current meta-analysis.
In a unique meta-analysis published in 2015 [9] , Sutterland et al. assessed the prevalence of T. gondii infection in several psychiatric disorders using both published and unpublished studies. They obtained a non-significant OR of 1.2 indicating no general difference between healthy subjects and depressed patients in terms of T. gondii infection prevalence. Since the present study only included the published studies, 7 out of the 9 studies reviewed in the mentioned study were investigated in the current meta-analysis. One of the two non-investigated studies was unpublished, and the other study was a summary of the paper presented at a congress [52] . In addition, 22 studies were not investigated in the mentioned meta-analysis; however, they were included in the current study due to meeting our inclusion and exclusion criteria.
The advantages of this meta-analysis are as follows: 1) the investigation of a larger number of cases and controls, compared to those of the previous studies that improves the statistical power to assess the association between toxoplasmosis and depression, 2) inclusion of studies from eight other countries in the meta-analysis that intensifies the consistency of the association, 3) analysis of case-control and cross-sectional studies based on OR, and 4) exclusive attention to MDD.
According to Fig 2, the lowest and highest ORs are related to the studies performed by Massa et al. [46] and Conejero-Goldberg et al. [22] , respectively. This difference could be due to the sole use of postmortem brain samples by Conejero-Goldberg et al. [22] . In addition, the quality of the mentioned study was low, and the number of the subjects was small. However, Massa et al. used a larger sample size with a different set of psychiatric diagnoses. Moreover, race, educational level, and economic status can result in different ORs [46] . Difference in the sensitivity and specificity of detection methods, different geographic regions, age, gender, and ethnic groups are the main reasons for the difference in the prevalence of T. gondii [6, 9, 53] . Given the incomplete data of the studies assessing the relationship between different variables (e.g., age, gender, ethnic, diet, family history, parasite strain, socioeconomic level) and the prevalence of toxoplasmosis, meta-analysis was not applicable for these variables. Furthermore, due to the lack of the evaluation of these risk factors in some studies, these variables cannot be analyzed; accordingly, this is considered as a basic gap.
For example, the gender agent has an apparent impact on the psychomotor performance of humans [54] . Female sex hormones are known to manipulate dopaminergic actions in some parts of the brain. The occurrence of degenerative disorders in women, such as Parkinsonism, decreases the protective effect of dopamine [55] . Conversely, higher levels of testosterone in men can cause toxoplasmosis associated with changes in human and animal behaviors [56] . Therefore, this variable is important in evaluating the relationship between depression and T. gondii and needs to be addressed.
The possible mechanism underlying the behavioral changes correlated with latent toxoplasmosis is the presence and spread of T. gondii cysts in the central nervous system. Berenreiterová et al. [57] reported that Toxoplasma latent cysts in mice were distributed all over the brain; it would seem possible that parasitic cysts in these areas in humans could alter both frontal and limbic regions which could then result in behavioral and emotional changes. Tryptophan catabolic shunt and serotonin during reactivation stage of T. gondii infection may contribute to the development of depressive-like behavior [58] . In addition, neuronal function and immune-mediated dopamine and serotonin synthesis may be the mechanism of contribution of T. gondii infection to behavioral disorders [59] . The production of a large amount of dopamine by parasite increases the destruction of the cyst walls and production of tachyzoites [60] . In a study, the treatment of rats with latent toxoplasmosis by means of a dopamine-2 antagonist resulted in the reduction of their risky behaviors [61] .
T helper 1 (Th1), natural killer cells, and nitric oxide interfere in host response to T. gondii infection. The Th1 cells secrete interferon-γ (IFN-γ) and pro-inflammatory cytokines that are important in impeding tachyzoite replication and preventing the reactivation of the tissue cysts of the central nervous system [62] . Inflammatory cytokines, such as IFN-c, tumor necrosis factor-a, and interleukin 6, are parts of the inflammatory response to T. gondii, leading to the production of glucocorticoids, which affects neuroplasticity [63] . Reduced serotonin production and tryptophan depletion in the brain may contribute to the incidence of depression caused by such cytokines as IFN-γ that could lead to the activation of indoleamine 2, 3-dioxygenase [64, 65] . Activation of guanosine-triphosphate-cyclohydrolase-1 by IFN-γ and other pro-inflammatory cytokines (e.g., IFN-α and IFN-β) increases the production of neopterin, enhances nitrate concentration through the production of tetrahydrobiopterin, and decreases phenylalanine and tyrosine levels. Amine acid phenylalanine has a key role in the biosynthesis of norepinephrine and dopamine. Sleep disturbance, fatigue, and disorders of the gastrointestinal and musculoskeletal systems are associated with decreased dopamine synthesis [64] . In a study, it was reported that the signs and symptoms of depression were ameliorated after the treatment of T. gondii infection although patient was unresponsive to the conventional antidepressants [66] .
Limitations
There are several restrictions in our research. One of these limitations was the adoption of different sampling techniques, such as Facebook-based snowball method, in various studies. Investigation of different age groups in different studies was another limitation since individuals with a longer duration of Toxoplasma seropositivity could have a higher level of depression. The type of studies reviewed is also a limitation of this study as the nature of cross-sectional study did not allow us to investigate possible causal relationships between T. gondii and depression. Also, in most case-control studies, the case and control groups were matched for age and sex, but cross-sectional studies cannot be matched for age and sex and therefore may be one of the reasons for the difference in the significance level of studies. In some cross sectional studies, despite having a large population-based study sample, the number of participants with depression was still limited, and the lack of significant association of T. gondii with depression despite higher prevalence in seropositivity and higher serointensity may reflect limited statistical power. Another limitation was that most of the included studies did not have sufficient information on disease status or severity. In addition, the studies had variable quality. Furthermore, a few studies were conducted on limited population, such as pregnant women; therefore, the results cannot be extrapolated to the general population. As the final limitation, the reviewed studies did not evaluate the effect of Toxoplasma strains on depression.
Conclusions
Based on the results of this meta-analysis, no statistically significant association was observed between toxoplasmosis and MDD. However, according to the results of the reviewed studies, especially those of the case-control studies, the potential role of toxoplasmosis in depression cannot be completely ruled out. Therefore, it is necessary to perform further research to clarify the role of T. gondii exposure in the clinical characteristics of MDD and determine the detailed association between T. gondii and dysthymia or mild and moderate depression. In addition, it is recommended to evaluate the effect of the antibody titers on the association between depression and Toxoplasma.
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